E. Brian Francisco

Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers

François Moisan, E. Brian Francisco, Anamaria Brozović et al. · Molecular Oncology · 2014 · 115 citations · Full text

The miR‐200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR‐3 and MES‐OV cells

Anamaria Brozović, George E. Durán, Yan C. Wang et al. · Molecular Oncology · 2015 · 101 citations · Full text

Mechanisms of Resistance to Cabazitaxel

George E. Durán, Yan C. Wang, E. Brian Francisco et al. · Molecular Cancer Therapeutics · 2014 · 95 citations · Full text

Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition

George E. Durán, Yan C. Wang, François Moisan et al. · British Journal of Cancer · 2017 · 47 citations · Full text